glp-1 dual agonist Trends in the Development of Receptor Agonists Structural analysis of the dual
Description
Use of dipeptidyl peptidase-4 inhibitors for type 2 diabetes mellitus and risk of fracture
Additional questionnaires Participants reported on the good effects, the bad effects, taste and liking of alcohol during the alcohol administration session
There are currently no FDA-approved GLP-1 receptor agonists that can be administered orally
-cell dysfunction: its critical role in prevention and management of type 2 diabetes
Nat Commun 6 , 8918 (2015)
